Oncology & Cancer

When good immune cells turn bad

Investigators at the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles have identified new findings about an immune cell - called a tumor-associated macrophage - that promotes cancer instead ...

Oncology & Cancer

Beta-adrenergic receptor signaling affects tumor microenvironment

(HealthDay)—β2-adrenergic receptor (β-AR) signaling in host immune cells regulates CD8+ T-cell frequency and functional orientation within the tumor microenvironment, according to a study published online Aug. 17 in Cancer ...

Oncology & Cancer

Researchers propose new strategy to treat cancer

Whenever an organism is damaged, the cells surrounding the wound receive signals to proliferate more intensely to regenerate the injured tissue. The same thing happens with cancer—tumor cells may be all but eliminated by ...

Oncology & Cancer

Telomere length prognostic in hepatocellular carcinoma

(HealthDay)—Telomere attrition occurs in tumor cells from patients with hepatocellular carcinoma (HCC), and shortened telomeres are independent prognosticators for HCC patients, according to a study published online Aug. ...

Oncology & Cancer

Spread of breast cancer reduced by targeting acid metabolite

It's a metabolite found in essentially all our cells that, like so many things, cancer overexpresses. Now scientists have shown that when they inhibit 20-HETE, it reduces both the size of a breast cancer tumor and its ability ...

Oncology & Cancer

Immune cells play crucial role in brain cancer development

Brain tumors recruit immune cells derived from bone marrow to transform what began as benign masses into deadly malignancies, according to two studies from Weill Cornell Medicine scientists. The findings suggest that inhibiting ...

page 33 from 40